30K iOS Apps Tracked Updated 5 min ago Revenue Forecasts
Add an app Create Account Sign In
Home

Endo-Enzian

0
Quality Score
Niche

Endo-Enzian

by Medarus KG Dr. Ebner GmbH & Co
Low confidence
— App Store rating
✍️ Bumetric analysis
“

Endo-Enzian is an iOS app from Medarus KG Dr. Ebner GmbH & Co in the News category, currently rated — across few ratings. Initial signal reads as no scraped reviews yet: judgment based on metadata only.

Quality Score is 0: Niche (micro-niche or pre-traction stage). For a News app, that means micro-niche or pre-traction stage. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.

Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.

💰 Monthly revenue · now vs forecast
● Right now
$500
per month
→
12-mo forecast
$437 – $1575
per month
→
24-mo forecast
$405 – $3644
per month
INDIE tier
💡 Grow this revenue
Free AI audit of this app’s store listing
  • Title & subtitle keyword fit
  • Description hook & conversion structure
  • Screenshots, ratings, reviews strategy
Run free AI audit →
Typical impact: +2-5× organic installs
🔔Notify me when this app's revenue changes by

📊 Performance Tracking LIVE

7 snapshots on record
idle
0%
Rating
—
Reviews
0 reviews
Forecast Revenue / mo
$500
Snapshots tracked
7
since Mar 2026
ONE-TIME · BUILD 💰 Estimated build cost
$80K
↳ What it cost to build · not monthly revenue
Likely range $60K – $110K
$25K · MVP floor $100K · indie scale $500K+ · studio build
📈 Slow ROI — current MRR is well below build cost

Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.

Where the money goes
🧱 MVP baseline (design + 1-store ship) +$28K
📱 5 unique screens × $4.5K +$22K
⚙ News complexity ×1.20 +$10K
⚙ 2.9y maintenance × ~1-person team +$17K
Total estimate $80K
ONE-TIME · EXIT VALUE 💵 Estimated acquisition value
$10K
↳ What it would sell for · not monthly revenue
Marketplace range $5K – $10K · 16× MRR multiple
💸 ~0.1× build cost (under-water)

Synthetic estimate. Multiple band derived from ad-supported + age, rating quality, category demand, and user-base maturity. Calibrated against 2024-2026 indie-app-marketplace closed-deal medians. Full math + comparable deal list on /methodology.

How the multiple was built
📺 Ad-supported base 15× MRR
📅 2.9y proven track record +15%
🏷 News category multiple -5%
Final multiple 16× MRR
🛠 Estimated tech stack
🍎
Native iOS (SwiftUI)
High confidence · 80%
Also possible
Native iOS (Swift / UIKit)

Heuristic guess from app bundle size, category, store description signals, and release-date stack era. Bumetric does not disassemble binaries — for binary-level certainty you would need an SDK intelligence tool or the manifest itself. Reasoning chain on the right. Full ruleset on /methodology.

Signals we read
📦 App bundle size 7 MB
🏷 Category context News
📦 Compact iOS bundle → Native SwiftUI (post-2020 era)
💀 Maintenance status
Likely abandoned
88%
Last shipped 2024-04-03 · 960 days ago
0 · Active 50 · At risk 100 · Abandoned

Heuristic risk score from time-since-last-update + ratings velocity proxy + Editor's Choice / curated featuring signals. Calibrated against 2024-2025 app-store ranking decay reports. Not a guarantee — a quiet app with a healthy codebase looks the same as an abandoned one until something breaks. Full math on /methodology.

Risk signals
📅 2y+ since last update Likely abandoned
Verdict Likely abandoned
🔬

How we forecast this revenue

LOW CONFIDENCE
Baseline
$500/mo · ML-estimated from 234 triggers
Growth rate
+6.0% MoM · INDIE tier baseline (compound monthly)
Direction
Headwinds: rating drift may slow acquisition, low defensibility moat
6 months
$426 – $993
12 months
$437 – $1.6K
24 months
$405 – $3.6K
Compound growth at +6.0% MoM (tier baseline for INDIE). Range widens with horizon — typical noise band ±40% at 6mo.. Ranges widen with horizon — distant futures carry more uncertainty.
📊

BU Investment Matrix

Pre-traction · 30/100INDIE TIERlimited signal
GrowthFounderQualityRevenueMonetiz.MoatMarketSafety
Growth Velocity
5.0
Founder Strength
3.3
Product Quality
0.0
Revenue Strength
2.7
Monetization Maturity
1.0
Defensibility
2.7
Market Position
2.0
Operational Safety
7.0
  • 💰 Revenue: Marginal — $200 - $1250/mo · INDIE tier · medium confidence, trajectory unclear.
  • ⭐ Quality: None★ across 0 reviews — weak — significant quality concerns.
  • 📍 Market: Not yet charting in any of the 9 monitored markets.
  • 📈 Growth: ⚠ last update 959d ago — possibly dormant.
  • ⚠️ Risk: Moderate — dormant (959d since update).
🎯 For competitors: Mixed picture. Worth competing if you have a clear UX or pricing edge — otherwise crowded segment.
💵 For acquirers: Estimated asking range 18-32× monthly = $9K-$16K.
Composite of 8 dimensions computed deterministically from public signals — no LLM, every score traces back to a measurable input. Default weights shown; "compete" / "acquire" / "invest" lenses re-weight without re-fetching.
Range:

💰 Forecast Revenue / mo

MODEL
Revenue forecast computed from BU's 234 trigger model on each snapshot. Calibrated against ground-truth from 58 verified-revenue apps.
🔬Forecast Breakdown — Why This Estimate?Top 3 of 3 triggers
Our ML model uses 200+ signals from public data. These are the most influential for this app:
Paid app ($0.99)METRIC
+$2,800
Single-language (English only)METRIC
−$400
Growing app (2y old)METRIC
+$200
METRIC = structural app data · REVIEW = mined from user reviews · ✓ VERIFIED = Stripe-verified anchor (TrustMRR)

📈 Reviews Growth

LIVE
Cumulative review count from first BU snapshot. Each point = a tracked update.

⭐ Rating Trend

LIVE
Average rating evolution. Updates with each new review batch.

🆕 What's New · v1.2

Diese App wurde von Apple aktualisiert, um ihre Kompatibilität mit watchOS 27 sicherzu­stellen. Es sind keine neuen Funktionen enthalten.

iWatch Anbindung mit Scrollfunktion des Uhrrads. Macht die Handhabung schneller und einfacher und den Score noch alltäglicher.

Profile & Insights

Everything we know — and don't — about this app and its company.

Identification

App name
Endo-Enzian
Developer
Medarus KG Dr. Ebner GmbH & Co
Bundle ID
Not found
App Store URL
Open in App Store
Category
News
Content rating
12+
Languages
EN

Company

Website
Not found
Tagline
Today
Description
Find apps and games for iPhone, iPad, Mac, and more on the App Store.
Founded
Not found
HQ / Address
Not found
Employees
Not found
Logo
Available

Revenue

Reported revenue signal / mo
Not found
AI revenue estimate / mo
Not found
AI annual estimate
Not found
Model estimate / mo
$500/mo
Top-grossing rank
Not found
All-time revenue
Not found
Pricing
Not found

Founder

Founder data not yet collected for this app.

Funding

Funding data not yet collected for this app.

Press & Links

Press & Links data not yet collected for this app.

Contacts & Socials

Contacts & Socials data not yet collected for this app.
🌍Geographic ReachNot ranked
This app is currently outside the top 100 grossing in all 9 countries we monitor (US, UK, DE, FR, JP, CA, AU, BR, IN). Niche or new apps often launch this way — popularity rankings appear once daily revenue clears the regional threshold.
💰Pricing History$0.00 → $0.99 (+0%)
Profile is built from iTunes Lookup + developer site scrape + ML revenue model. Empty fields show "Not found" — additional sources (Crunchbase, X, IndieHackers, Acquire.com) coming.

📝 About this app

Ok, mir war es zu d**f immer nach der Vorlage für den #Enzianscore zu suchen im Op Bericht/Arztbrief den Situs ordentlich zu beschreiben. Jetzt geh ich aus der Op raus und tippe den Befund in die App und kann direkt den Score auf das (analoge - sic!) Op Protokoll schreiben. Das war mir die Programmierer wert. Damit anderen der (Doku-)Frust erspart bleibt stelle ich die App online für jeden (Arzt).

Damit keiner sagen kann er/sie wusste es nicht: Diese App ist zur Klassifizierung des Operationsbefundes und enthält keine Therapie oder Behandlungshinweise.… View full description on the official store →
App Specs
🔐 Own this app? Claim & verify MRR →
💾 7 MB🔞 12+📱 iOS 16.4+🔖 v1.2🔄 updated 2y ago🌐 EN📂 News💰 Paid🚀 Launched 2023 (2y old)
📅

What Worked™ · Development Pipeline

2 EVENTS TRACKED
Detected changes in this app over its tracked lifetime — each event links cause (what changed) to effect (what moved). Sorted newest first.See full history →Version history →
2026-06
💲
Went paid — introduced $0.99 price point
2026-03
🚀
First tracked snapshot — initial data captured
🌍

Multi-Country Performance

Available in 9 of 9 monitored markets
MarketRatingReviewsCurrent version
🇦🇺 AU0★0—
🇧🇷 BR0★0—
🇨🇦 CA0★0—
🇩🇪 DE0★0—
🇫🇷 FR0★0—
🇬🇧 GB0★0—
🇮🇳 IN0★0—
🇯🇵 JP0★0—
🇺🇸 US0★0—
🔔

Track this app’s revenue

FREE
Get an email when revenue moves by your threshold. No spam, unsubscribe in one click.

📝 Description

95
BU Score · Transcendent

Similar apps in News

About this analysis
ZCAnalyzed by Zakhar Chumak · founder, Bumetric·Full methodology·Low confidence

Why low confidence: only 0 ratings · no founder-verified revenue (model estimate only) · revenue figure is directional only.

📌 Final verdict — read this before you trust the numbers above

Endo-Enzian is a very early-stage iOS app in the news space with weak public traction — only 0 ratings, no founder-verified MRR, and not ranked in any monitored grossing chart. The app appears to be monetised, but public signals are too sparse for a precise revenue estimate.

Bottom line: treat all revenue, audience and acquisition-value numbers on this page as directional only — not founder-verified facts.

❓ Frequently Asked Questions

6 answers · auto-generated from this app's public data
How much does Endo-Enzian make per month?▴
Low-confidence model estimate. Endo-Enzian has only 0 App Store ratings, so our revenue model has very little signal to work with — treat the ~$500/mo figure as directional only, not a verified MRR. No founder-verified revenue data is available for this app. See methodology for the formula and confidence bands.
What apps are like Endo-Enzian?▴
Browse the full News category catalog to find similar apps with revenue, build cost, audience and tech stack data. Each /p/{slug} page also shows a Compare side-by-side widget with three peer apps from the same niche.
What is Endo-Enzian built with?▴
Our heuristic places Endo-Enzian on the Native iOS (SwiftUI) stack (High confidence, 80%). Signals: app bundle size, category context, store-description markers, release-date era. We don't disassemble binaries. Alternative possibilities: Native iOS (Swift / UIKit).
Is Endo-Enzian still actively maintained?▴
Maintenance status: Likely abandoned (88% abandonment risk). Last shipped version was 2+ years ago. The risk score combines time-since-last-update with Editor's Choice / curated featuring + user-base maturity adjustments.
When was Endo-Enzian last updated?▴
Endo-Enzian last shipped a new version on 2024-04-03 — more than 2 year(s) ago. This is the date Apple / Google last accepted a new build, not a content-only push.
Who makes Endo-Enzian?▴
Endo-Enzian is published by Medarus KG Dr. Ebner GmbH & Co on the Apple App Store. See the full publisher portfolio (other apps by the same developer) via the More by developer block on the product page above.